Macro-CK type 2 in metastatic prostate cancer-Reference-Cited by-同舟云学术

Macro-CK type 2 in metastatic prostate cancer

Published:2018-11-09 Issue:3 Volume:6 Page:307-309
ISSN:2194-802X
Container-title:Diagnosis
language:en
Short-container-title:

Author:

Eidizadeh Abass¹,von Ahsen Nicolas²,Friedewald Steffen³,Binder Lutz²

Affiliation:

1. Universitätsmedizin Göttingen, Georg-August-Universität Göttingen, Institut für Klinische Chemie , Robert-Koch-Str. 40 , 37075 Göttingen , Germany , Phone: 0551 39-8549

2. Institute for Clinical Chemistry, University Medical Center Goettingen , Goettingen , Germany

3. Institute for Laboratory Diagnostics, Elbe Kliniken Stade-Buxtehude , Stade , Germany

Abstract

Abstract The isoenzyme creatine kinase muscle/brain (CK-MB) still plays an important role for the differential diagnosis of CK elevations and the clarification of their origin from heart or skeletal muscle. Therefore, it is necessary to know the diagnostic pitfalls in interpreting CK-MB results. We demonstrate a case of macro-CK type 2 in a 75-year-old patient with metastatic castration-resistant prostate cancer and its identification by isoenzyme electrophoresis, which can be typical for cancer diseases.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,Public Health, Environmental and Occupational Health,Health Policy,Medicine (miscellaneous)

Link

https://www.degruyter.com/document/doi/10.1515/dx-2018-0039/pdf

Reference13 articles.

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Task force for the universal definition of myocardial infarction: third universal definition of myocardial infarction. Nat Rev Cardiol 2012;9:620–33.

2. Axinte C, Alexa T, Cracana I, Alexa ID. Macro-creatine kinase syndrome as an underdiagnosed cause of ck-mb increase in the absence of myocardial infarction: two case reports. Rev Med Chir Soc Med Nat Iasi 2012;116:1033–8.

3. Sturk A, Sanders GT. Macro enzymes: prevalence, composition, detection and clinical relevance. J Clin Chem Clin Biochem 1990;28:65–81.

4. Remaley AT, Wilding P. Macroenzymes: biochemical characterization, clinical significance, and laboratory detection. Clin Chem 1989;35:2261–70.

5. Lee, Csako G, Bernhardt P, Elin RJ. Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. Clin Chem 1994;40(Pt 1):1278–83.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Creatine Kinase (CK)-MB and CK-MB-to-Total-CK Ratio: A Novel Predictive Marker for Pathologic Complete Response in Breast Cancer Treated with Neoadjuvant Chemotherapy;International Journal of Hematology and Oncology;2024-06-30

2. Prognostic value of creatine kinase (CK)-MB to total-CK ratio in colorectal cancer patients after curative resection;BMC Cancer;2024-04-29

3. Prognostic value of Creatine Kinase (CK)-MB to total-CK ratio in colorectal cancer patients after curative resection;2023-11-16

4. Evaluation of creatine kinase (CK)-MB to total CK ratio as a diagnostic biomarker for primary tumors and metastasis screening;Practical Laboratory Medicine;2023-11

5. Prognostic impact of Creatine Kinase (CK)-MB to total-CK ratio following curative resection of stage I-III colorectal cancer;2023-05-26